In AD patients, induction of hippocampal proliferation is one of the potential therapeutic tools, and irisin can promote hippocampal and neuronal proliferation and improve synaptic function by upregulating BDNF expression and subsequently STAT3 signaling (Rabiee et al., 2020). This evidence concerns the gene BDNF and Alzheimer disease.